© 2025 NPR Illinois
The Capital's Community & News Service since 1975
Donate
NPR Illinois
Morning Edition
NPR Illinois
Morning Edition
Next Up: 9:00 AM On Point
0:00
0:00
Morning Edition
NPR Illinois
0:00 0:00
Available On Air Stations
Get involved now! ProtectMyPublicMedia.org Make the call.

A clinical trial of a drug treating Alzheimer's was successful. What does that mean for patients?

Published October 5, 2022 at 12:52 PM CDT
A woman, suffering from Alzheimer's desease, holds the hand of a relative on March 18, 2011 in a retirement house in Angervilliers, eastern France. (Sebastien Bozon/AFP via Getty Images)
A woman, suffering from Alzheimer's desease, holds the hand of a relative on March 18, 2011 in a retirement house in Angervilliers, eastern France. (Sebastien Bozon/AFP via Getty Images)

Here & Now‘s Scott Tong speaks with STAT’s biotech reporter Damian Garde about a promising study of a drug that could reduce the cognitive effects of Alzheimer’s disease.

This article was originally published on WBUR.org.

Copyright 2022 NPR. To see more, visit https://www.npr.org.